| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $1,609,558 ) |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01NS119517 | Novel Modulators of TGFß1 signaling in regulation of remyelination by neural stem cells | 000 | 5 | NIH | 12/5/2025 | $335,675 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI182884 | Maternal vaccination impacts on neonatal susceptibility and response to Bordetella pertussis | 000 | 2 | NIH | 12/4/2025 | $181,080 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R61AI187112 | Establishing strains and conditions for long-term P. vivax cultures | 000 | 2 | NIH | 12/3/2025 | $379,960 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI173144 | Impacts of host lipid composition on antimicrobial susceptibilities of Staphylococcus aureus | 000 | 4 | NIH | 12/8/2025 | $477,462 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AG076625 | Implications of Metabolic Dysfunction during Thiamine Insufficiency | 000 | 4 | NIH | 12/10/2025 | $331,600 |
| | 2026 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | U01AG074960 | Novel Reengineered Microbiome-based Biologic Therapy to Treat Cognitive and Behavioral Symptoms of Alzheimer's Disease and Related Dementias | 000 | 4 | NIH | 12/11/2025 | $0 |
| | 2026 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | T32AI060546 | Training in Tropical and Emerging Global Diseases | 000 | 20 | NIH | 11/19/2025 | -$96,195 |
| | 2026 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | T03OH012806 | Translating the Fisherman First Aid and Safety Training (FFAST) for Commercial Fishermen in the Southeastern United States | 02 | 1 | CDC | 11/13/2025 | $0 |
| | 2026 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI171944 | Extracellular vesicles encapsulating CRISPR machinery for treatment of SARS-CoV-2 infection | 000 | 2 | NIH | 12/1/2025 | $0 |
| | 2026 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01CA257851 | Development of a novel biodegradable inorganic nanoparticle therapeutic for cancer | 000 | 4 | NIH | 11/21/2025 | $0 |
| | 2026 | 2023 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21NS128750 | Screening using split fluorescent protein tags for neurotransmitter receptors that define a synaptic balance in neuralcircuits | 000 | 1 | NIH | 12/2/2025 | $0 |
| | 2026 | 2022 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R00ES030015 | Role of Aflatoxin-induced DNA Damage Formation and Repair in Hepatic Mutagenesis | 000 | 4 | NIH | 12/5/2025 | $0 |
| | 2026 | 2022 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AA025911 | Using Neuroeconomics to Understand Alcohol Overvaluation in Alcohol Use Disorder | 000 | 5 | NIH | 12/5/2025 | -$24 |
|
| Issue Date FY: 2025 ( Subtotal = $65,751,269 ) (Continued on the next page) |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM153189 | Analysis of Metabolic Stress and Functional Integration in Prokaryotes | 001 | 2 | NIH | 4/9/2025 | $377,500 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | K99AI177948 | State of the ART: Functional genomics of RNA-binding proteins and their role in artemisinin drug resistance in Plasmodium falciparum | 001 | 2 | NIH | 4/30/2025 | $122,119 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | K01HD110683 | State economic support policies on the prevention of child abuse and neglect during and post the COVID-19 pandemic: Bridging evidence with policy implementation | 000 | 4 | NIH | 8/5/2025 | $132,381 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI175925 | Development of ganglioside specific IgGs for the treatment of Guillian-Barré Syndrome | 000 | 2 | NIH | 12/6/2024 | $182,243 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01NS114567 | Genipin’s ECM Crosslinking Action as an Agent to Prevent Neurodegeneration in Familial Dysautonomia | 001 | 5 | NIH | 6/13/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01NS114567 | Genipin’s ECM Crosslinking Action as an Agent to Prevent Neurodegeneration in Familial Dysautonomia | 004 | 6 | NIH | 9/4/2025 | -$199,107 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01NS114567 | Genipin’s ECM Crosslinking Action as an Agent to Prevent Neurodegeneration in Familial Dysautonomia | 003 | 5 | NIH | 8/28/2025 | -$199,107 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01NS114567 | Genipin’s ECM Crosslinking Action as an Agent to Prevent Neurodegeneration in Familial Dysautonomia | 002 | 6 | NIH | 6/16/2025 | $569,730 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01NS114567 | Genipin’s ECM Crosslinking Action as an Agent to Prevent Neurodegeneration in Familial Dysautonomia | 000 | 5 | NIH | 11/27/2024 | $339,750 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI180920 | Comparative transcriptomics of Plasmodium vivax strains to understand hypnozoite formation | 000 | 2 | NIH | 4/30/2025 | $188,750 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01HD114750 | Mechanisms of uterine fluid absorption during early pregnancy | 000 | 2 | NIH | 4/4/2025 | $648,318 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AA026362 | The Neurokinin-1 Receptor as a Mediator of Alcoholism and Depression Comorbidity | 002 | 7 | NIH | 8/26/2025 | $340,623 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AT012783 | Multi-omics approaches to lower the barriers to sustainable production of plant natural products with relevance to human health | 000 | 2 | NIH | 12/6/2024 | $485,272 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM152057 | Regulation of protein transport in cilia | 002 | 2 | NIH | 8/14/2025 | $54,481 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM152057 | Regulation of protein transport in cilia | 001 | 2 | NIH | 11/13/2024 | $490,327 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM152134 | Control and function of repressive chromatin domains | 001 | 2 | NIH | 5/30/2025 | $365,002 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01HL134899 | Engineering nitric oxide releasing polymer with immobilized thrombin inhibitor for blood contacting applications | 000 | 8 | NIH | 12/10/2024 | $374,185 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | F31AI181492 | The impact of the mosquito gut microbiota on regulation of egg formation and malaria infection | 001 | 2 | NIH | 8/8/2025 | $16,000 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | F31AI181492 | The impact of the mosquito gut microbiota on regulation of egg formation and malaria infection | 000 | 2 | NIH | 7/23/2025 | $33,538 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM151237 | Developmental mechanisms that buffer mutational load in plants | 000 | 3 | NIH | 6/6/2025 | $360,480 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01DK132673 | Transfer application - Leptin in the VMH and energy balance | 001 | 4 | NIH | 8/20/2025 | $377,500 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01NS133739 | Defining the mechanisms of MSC extracellular vesicle modulation of microglia metabolism and bioenergetics in traumatic brain injury recovery | 000 | 2 | NIH | 7/28/2025 | $621,942 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R00GM138759 | Uncovering mechanisms controlling chromosome-specific behaviors during meiosis | 000 | 5 | NIH | 6/4/2025 | $248,853 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | DP2AI184725 | Evolution of heat tolerance and drug resistance in Cryptococcus | 000 | 2 | NIH | 7/31/2025 | $443,944 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01GM147312 | Functional Analysis of the Anti-Müllerian Hormone as a Convergently Acquired Master Sex Determination Gene | 000 | 3 | NIH | 4/28/2025 | $311,077 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM147209 | Spatial genetics investigation of multinucleated cells | 000 | 4 | NIH | 7/23/2025 | $377,500 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01HL170574 | Prevention of catheter related infections via photoactive nitric oxide delivery device | 000 | 3 | NIH | 5/21/2025 | $475,865 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI140719 | Cryptococcal vaccine development based on strong immunity induced by morphological strains | 002 | 7 | NIH | 4/30/2025 | $577,493 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AG074216 | APOE4 effects on glia-neuron interaction in the olfactory bulb | 001 | 3 | NIH | 6/9/2025 | $36,016 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AG074216 | APOE4 effects on glia-neuron interaction in the olfactory bulb | 000 | 3 | NIH | 3/7/2025 | $405,192 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI193187 | Characterizing a feedback signal balancing lipopolysaccharide and glycerophospholipid synthesis in Gram negative bacteria | 000 | 1 | NIH | 8/21/2025 | $415,250 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM158412 | Merging bacteriophage biology with microbial glycobiology | 000 | 1 | NIH | 7/4/2025 | $377,500 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R33AI169204 | Novel Nanoparticle Respiratory Tract Mucosal Vaccine | 000 | 4 | NIH | 8/21/2025 | $381,855 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R33AI169204 | Novel Nanoparticle Respiratory Tract Mucosal Vaccine | 000 | 4 | NIH | 8/21/2025 | $381,854 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM156839 | Chromosome-specific meiotic biology | 000 | 1 | NIH | 8/18/2025 | $160,613 |
|
